Pfizer Inc (PFE)

Inventory turnover

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cost of revenue	US$ in thousands	16,420,000	29,687,000	34,344,000	30,821,000	8,692,000
Inventory	US$ in thousands	10,851,000	10,189,000	8,981,000	9,059,000	8,046,000
Inventory turnover		1.51	2.91	3.82	3.40	1.08

December 31, 2024 calculation

Inventory turnover = Cost of revenue ÷ Inventory
= $16,420,000K ÷ $10,851,000K
= 1.51

Pfizer Inc's inventory turnover has exhibited fluctuations over the past five years. In December 2020, the inventory turnover was 1.08, indicating that the company's inventory was turning over approximately once a year. However, there was a significant improvement in efficiency as of December 2021, with the inventory turnover increasing to 3.40, suggesting that Pfizer's inventory was being sold and replaced approximately 3.4 times during that year.

The trend continued positively in December 2022, with the inventory turnover further increasing to 3.82, indicating an even higher level of inventory efficiency. However, there was a slight decrease in December 2023, as the inventory turnover dropped to 2.91, although it still remained relatively high compared to previous years.

In December 2024, Pfizer experienced a notable decline in inventory turnover to 1.51, suggesting a decrease in inventory efficiency compared to the previous year. Overall, while there have been fluctuations in Pfizer's inventory turnover, the general trend has shown improvements in inventory management efficiency, with some variability in recent years.